Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashour Mohammed

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Melanoma Research|October 1, 2004
Alkylating benzamides with melanoma cytotoxicityMarkus Wolf, Ulrike Bauder-Wüst, Ashour Mohammed, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2002
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrileMarcus Henze, Ashour Mohammed, Walter Mier, et al.
Journal of Medicinal Chemistry|December 13, 2002
Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural elementMichael Eisenhut, Ashour Mohammed, Walter Mier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2002
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPETMarcus Henze, Ashour Mohammed, Heinz Schlemmer, et al.
Nuclear Medicine and Biology|April 25, 2006
(99m)Tc complexes with activated ester functions; ligands comprising a 3,4-diamino-benzoate backboneOsmar Calderon Sanchez, Ashour Mohammed, Claudia Bauer, et al.
Nuclear Medicine and Biology|January 27, 2004
Pharmacological properties of hydrophilic and lipophilic derivatives of octreotateQin Wang, Keith Graham, Thomas Schauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysisMarcus Henze, Ashour Mohammed, Heinz P Schlemmer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Melanoma Research|October 1, 2004
Alkylating benzamides with melanoma cytotoxicityMarkus Wolf, Ulrike Bauder-Wüst, Ashour Mohammed, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2002
Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrileMarcus Henze, Ashour Mohammed, Walter Mier, et al.
Journal of Medicinal Chemistry|December 13, 2002
Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural elementMichael Eisenhut, Ashour Mohammed, Walter Mier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2002
Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPETMarcus Henze, Ashour Mohammed, Heinz Schlemmer, et al.
Nuclear Medicine and Biology|April 25, 2006
(99m)Tc complexes with activated ester functions; ligands comprising a 3,4-diamino-benzoate backboneOsmar Calderon Sanchez, Ashour Mohammed, Claudia Bauer, et al.
Nuclear Medicine and Biology|January 27, 2004
Pharmacological properties of hydrophilic and lipophilic derivatives of octreotateQin Wang, Keith Graham, Thomas Schauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 10, 2004
PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysisMarcus Henze, Ashour Mohammed, Heinz P Schlemmer, et al.
Pageof 1